Clinical Trial Update: Phase 3 Trial to Evaluate the Efficacy and Safety of Aficamten Compared to Metoprolol Succinate in Adults With Symptomatic oHCM [Phase 3]

View source ↗

Summary

Phase 3 trial comparing aficamten to metoprolol succinate in adults with obstructive hypertrophic cardiomyopathy has completed; results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obstructive Hypertrophic Cardiomyopathy

Drugs mentioned

• Aficamten (aficamten)
• Metoprolol succinate (METOPROLOL SUCCINATE)

Snippet

Sponsor: Cytokinetics | Conditions: Obstructive Hypertrophic Cardiomyopathy (oHCM) | Phase 3 | Status: COMPLETED | Results posted: 2026-06-09